CYTOR and colorectal cancer: LINC00152 is highly expressed and acts as an oncogene in colorectal cancer (Ou et al., 2020), and it may enhance malignancy and may be a promising prognostic biomarker of cancers (Seo et al., 2019; Wang et al., 2020).